DrugNov 17, 2021
Acetaminophen Oral Suspension, 160 mg/5 mL recall — FDA D-0094-2022
cGMP Deviations: Product manufactured with contaminated raw ingredient.
Class IIFDA: TerminatedPrecision Dose Inc.
10,685drug recall records
953FDA Class I records
8firms with 5+ records
Aidapak Services, LLC537 records
Database records
Records — page 110
10,685 detailed records are currently available in this category.
DrugNov 17, 2021
Ezetimibe and Simvastatin Tablets, 10 mg/80mg, 500 tablet bottles recall — FDA D-0228-2022
Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity
Class IIFDA: TerminatedGolden State Medical Supply Inc.
DrugNov 17, 2021
Cetirizine hydrochloride, 10 mg tablets, 90-count bottle recall — FDA D-0096-2022
Labeling: Not Elsewhere classified: Product was relabeled as 90 tablet count product although it was a manufacturer in a box with 30 tablet count tablets.
Class IIIFDA: TerminatedA-S Medication Solutions LLC.
DrugNov 17, 2021
Tadalafil Tablets, USP 5 mg, 30 count bottle recall — FDA D-0230-2022
Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.
Class IIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
DrugNov 17, 2021
Tadalafil Tablets, USP 20 mg, 30 count bottle recall — FDA D-0231-2022
Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.
Class IIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
DrugNov 10, 2021
Lupin Pharmaceuticals Irbesartan and Hydrochlorothiazide Tablets USP, 300/12.5 mg a) 30 recall — FDA D-0090-2022
CGMP Deviations: impurity N-nitrosoirbesartan detected in API
Class IIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugNov 10, 2021
EZETIMIBE AND SIMVASTATIN Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, a) 30 recall — FDA D-0084-2022
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugNov 10, 2021
EZETIMIBE AND SIMVASTATIN Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/20 mg, a) 30 recall — FDA D-0082-2022
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugNov 10, 2021
EZETIMIBE AND SIMVASTATIN Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/80 mg, a) 30 recall — FDA D-0083-2022
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugNov 10, 2021
EZETIMIBE AND SIMVASTATIN Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/40 mg, 500 recall — FDA D-0085-2022
Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin…
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugNov 10, 2021
EZETIMIBE AND SIMVASTATIN Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, a) 90 recall — FDA D-0081-2022
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Class IIFDA: TerminatedDr. Reddy's Laboratories, Inc.
DrugNov 10, 2021
MERCK SHARP & DOHME Cubicin (daptomycin for injection), 500 mg per vial, Single-dose vial recall — FDA D-0093-2022
Presence of Particulate Matter: Identified as Glass Particles
Class IFDA: TerminatedMERCK SHARP & DOHME CORP
DrugNov 10, 2021
Bryant Ranch Prepack, Inc. dba BRP Methocarbamol 500mg Tablet recall — FDA D-0092-2022
Labeling: Label Error on Declared Strength; Bottles labeled as Methocarbamol 500 mg Tablets actually contain Methocarbamol 750 mg Tablets
Class IFDA: CompletedBryant Ranch Prepack, Inc. dba BRP Pharmaceuticals
DrugNov 10, 2021
Lupin Pharmaceuticals Irbesartan and Hydrochlorothiazide Tablets USP, 150/12.5 mg a) 30 recall — FDA D-0089-2022
CGMP Deviations: impurity N-nitrosoirbesartan detected in API
Class IIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugNov 3, 2021
Rizatriptan Benzoate Film Coated Tablets, 10 mg recall — FDA D-0078-2022
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Class IIIFDA: TerminatedMACLEODS PHARMA USA, Inc.
DrugNov 3, 2021
Rizatriptan Benzoate Orally Disintegrating Tablets 10mg, 18 Tablets recall — FDA D-0080-2022
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Class IIIFDA: TerminatedMACLEODS PHARMA USA, Inc.
DrugNov 3, 2021
Ultra Seal Advance Formula Pain Reliever recall — FDA D-0075-2022
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Class IIIFDA: TerminatedUltra Seal Corporation
DrugNov 3, 2021
Ultra Seal Afassco Pain Free Plus X-STRENGTH PAIN RELIEVER recall — FDA D-0077-2022
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Class IIIFDA: TerminatedUltra Seal Corporation
DrugNov 3, 2021
Lupin Pharmaceuticals Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle recall — FDA D-0091-2022
Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.
Class IIIFDA: TerminatedLupin Pharmaceuticals Inc.
DrugNov 3, 2021
Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, 12 Tablets (2 x 6 Unit-Dose Tablets) recall — FDA D-0079-2022
Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.
Class IIIFDA: TerminatedMACLEODS PHARMA USA, Inc.
DrugNov 3, 2021
Ultra Seal Vica-Cet BACK PAIN RELIEF recall — FDA D-0071-2022
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Class IIIFDA: TerminatedUltra Seal Corporation
DrugNov 3, 2021
Ultra Seal ZEE+ painaid ESF Extra-Strength Formula recall — FDA D-0072-2022
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Class IIIFDA: TerminatedUltra Seal Corporation
DrugNov 3, 2021
Ultra Seal AERO Tab PAIN RELIEVER recall — FDA D-0073-2022
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Class IIIFDA: TerminatedUltra Seal Corporation
DrugNov 3, 2021
Ultra Seal North by Honeywell PAIN STOPPER EXTRA STRENGTH recall — FDA D-0074-2022
Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.
Class IIIFDA: TerminatedUltra Seal Corporation
How to use this drug recall index
A drug recall record can include the reason for recall, firm, status, distribution pattern, quantity and FDA classification. This site does not provide medical advice; it organizes public recall information and links users back to official sources.
Recall Lookup USA keeps the last complete source record available when an official data service is temporarily unavailable. When a source provides only a few fields, we show only those known facts rather than padding the page with generic text.
What the database can and cannot tell you
This database is designed for discovery and reference. It can help you locate a relevant recall record, identify the recalling firm or NHTSA campaign, compare dates and classifications, and follow the official source. It is not a substitute for a VIN-specific NHTSA check, a manufacturer notice, medical advice or instructions issued by the recalling company.